Acceleron Pharma competitorsClear all

Portola Pharmaceuticals's top competitors include GBT (Global Blood Therapeutics), Theravance Biopharma and Supernus Pharmaceuticals.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Portola Pharmaceuticals
Portola Pharmaceuticals
Portola Pharmaceuticals is a biopharmaceutical company.
GBT (Global Blood Therapeutics)
GBT (Global Blood Therapeutics)
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
Theravance Biopharma
Theravance Biopharma
Theravance Biopharma is a biopharmaceutical company which provides medicines to treat serious illnesses.
Supernus Pharmaceuticals
Supernus Pharmaceuticals
Supernus Pharmaceuticals is focused on developing and commercializing products for the treatment of central nervous system.
Founding Date
Founding Date
2003
Founding Date
2012
Founding Date
1996
Founding Date
2005
Type
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
South San Francisco, US HQ
Planegg, DE
Amsterdam, NL
Locations
South San Francisco, US HQ
Zug, CH
Locations
Dublin, IE HQ
San Francisco, US
Locations
Rockville, US HQ
Rockville, US
Employees
Employees
32429% increase
Employees
352106% increase
Employees
3637% increase
Employees
4486% increase
Valuation ($)
Valuation ($)
1.4 b
Valuation ($)
1.7 b
Valuation ($)
449.1 m
Valuation ($)
1.4 b
Twitter followers
Twitter followers
951
Twitter followers
1.8 k
Twitter followers
N/A
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
227657
Alexa Website Rank
178894
Alexa Website Rank
203693
Employee Rating
Employee Rating
3.3
Employee Rating
4.5
Employee Rating
3.5
Employee Rating
3

Financial

Revenue (est.)
Revenue (est.)
$116.6m (FY, 2019)
Revenue (est.)
$123.8m (FY, 2020)
Revenue (est.)
$60.4m (FY, 2018)
Revenue (est.)
$520.4m (FY, 2020)
Cost of goods
Cost of goods
$44.4m (FY, 2019)
Cost of goods
$2m (FY, 2020)
Cost of goods
$715k (FY, 2018)
Cost of goods
$52.5m (FY, 2020)
Gross profit
Gross profit
$72.3m (FY, 2019)
Gross profit
$121.8m (FY, 2020)
Gross profit
$59.7m (FY, 2018)
Gross profit
$467.9m (FY, 2020)
Net income
Net income
($290.7m) (FY, 2019)
Net income
($247.6m) (FY, 2020)
Net income
($215.5m) (FY, 2018)
Net income
$127m (FY, 2020)

Funding

Total funding raised
Total funding raised
$ 295.1m
Total funding raised
$ 88.7m
Total funding raised
$ 55m
Total funding raised
$ 42m
For sources of this data, please see the company profile

View company profiles

GBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352

GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.

View company
Theravance Biopharma
HQ
Dublin, IE
Employees
363↑ 7% increase

Theravance Biopharma is a biopharmaceutical company which provides medicines to treat serious illnesses.

View company
Supernus Pharmaceuticals
HQ
Rockville, US
Employees
448↑ 6% increase

Supernus Pharmaceuticals is focused on developing and commercializing products for the treatment of central nervous system.

View company